332 related articles for article (PubMed ID: 25687106)
1. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
[TBL] [Abstract][Full Text] [Related]
2. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
3. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.
Heidinger O; Batzler WU; Krieg V; Weigel S; Biesheuvel C; Heindel W; Hense HW
Dtsch Arztebl Int; 2012 Nov; 109(46):781-7. PubMed ID: 23264826
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
5. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
[TBL] [Abstract][Full Text] [Related]
6. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
Fuhs A; Bartholomäus S; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
[TBL] [Abstract][Full Text] [Related]
9. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
10. Digital mammography screening: average glandular dose and first performance parameters.
Weigel S; Girnus R; Czwoydzinski J; Decker T; Spital S; Heindel W
Rofo; 2007 Sep; 179(9):892-5. PubMed ID: 17705112
[TBL] [Abstract][Full Text] [Related]
11. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
12. [Determination of interval cancer rates in the German mammography screening program using population-based cancer registry data].
Urbschat I; Heidinger O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):68-76. PubMed ID: 24357175
[TBL] [Abstract][Full Text] [Related]
13. Bilateral breast cancer: early detection with mammography.
Roubidoux MA; Helvie MA; Lai NE; Paramagul C
Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
[TBL] [Abstract][Full Text] [Related]
14. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
15. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
16. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
18. Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.
Braun B; Khil L; Tio J; Krause-Bergmann B; Fuhs A; Heidinger O; Hense HW
Dtsch Arztebl Int; 2018 Aug; 115(31-32):520-527. PubMed ID: 30149831
[TBL] [Abstract][Full Text] [Related]
19. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
20. Lower sensitivity of screening mammography after previous benign breast surgery.
van Breest Smallenburg V; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; van Beek M; Louwman MW
Int J Cancer; 2012 Jan; 130(1):122-8. PubMed ID: 21328339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]